CytoMed Therapeutics receives US patent for CAR-Gamma Delta T-cell technology

CytoMed Therapeutics’ CAR-gamma delta T cell technology has been granted a patent by the US Patent and Trademark Office (USPTO).

Leave a Reply

Your email address will not be published. Required fields are marked *